...
首页> 外文期刊>Molecular medicine. >Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules.
【24h】

Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules.

机译:基于与疾病相关的功能模块,消除癌症的隐藏遗传异质性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Discovering molecular heterogeneities in phenotypically defined disease is of critical importance both for understanding pathogenic mechanisms of complex diseases and for finding efficient treatments. Recently, it has been recognized that cellular phenotypes are determined by the concerted actions of many functionally related genes in modular fashions. The underlying modular mechanisms should help the understanding of hidden genetic heterogeneities of complex diseases. We defined a putative disease module to be the functional gene groups in terms of both biological process and cellular localization, which are significantly enriched with genes highly variably expressed across the disease samples. As a validation, we used two large cancer datasets to evaluate the ability of the modules for correctly partitioning samples. Then, we sought the subtypes of complex diffuse large B-cell lymphoma (DLBCL) using a public dataset. Finally, the clinical significance of the identified subtypes was verified by survival analysis. In two validation datasets, we achieved highly accurate partitions that best fit the clinical cancer phenotypes. Then, for the notoriously heterogeneous DLBCL, we demonstrated that two partitioned subtypes using an identified module ("cellular response to stress") had very different 5-year overall rates (65% vs. 14%) and were highly significantly (P < 0.007) correlated with the clinical survival rate. Finally, we built a multivariate Cox proportional-hazard prediction model that included 4 genes as risk predictors for survival over DLBCL. The proposed modular approach is a promising computational strategy for peeling off genetic heterogeneities and understanding the modular mechanisms of human diseases such as cancers.
机译:在表型明确的疾病中发现分子异质性对于理解复杂疾病的致病机理和寻找有效的治疗方法都至关重要。最近,已经认识到细胞表型是由许多功能相关基因以模块化方式的协同作用决定的。潜在的模块化机制应有助于理解复杂疾病的隐藏遗传异质性。在生物学过程和细胞定位方面,我们将推定的疾病模块定义为功能基因组,它们显着富集了在疾病样本中高度可变表达的基因。作为验证,我们使用了两个大型癌症数据集来评估模块正确划分样本的能力。然后,我们使用公共数据集寻找复杂弥漫性大B细胞淋巴瘤(DLBCL)的亚型。最后,通过生存分析验证了所鉴定亚型的临床意义。在两个验证数据集中,我们获得了最适合临床癌症表型的高精度分区。然后,对于臭名昭著的异质DLBCL,我们证明了使用已确定的模块的两个分区亚型(“细胞对应激的反应”)的5年总发生率差异很大(65%vs. 14%),并且差异显着(P <0.007) )与临床生存率相关。最后,我们建立了一个多变量Cox比例风险预测模型,其中包括4个基因作为DLBCL存活的风险预测因子。提出的模块化方法是一种有前途的计算策略,可用于消除遗传异质性并了解人类疾病(例如癌症)的模块化机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号